Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Interest-Income" stands at 0.412 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
Merck & Company Inc's third quarter result of 0.096 Billion USD for the item "Interest Income" represents an increase of 57.38 percent compared to it's second quarter result.
Also, Merck & Company Inc's third quarter result of 0.096 Billion USD for the item "Interest Income" represents a decrease of -24.41 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 0.412 Billion USD for the item "Interest Income" represents a decrease of -7.00 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 21.53 percent compared to the value the year prior.
The 1 year change in percent is 21.53.
The 3 year change in percent is -45.29.
The 5 year change in percent is 68.85.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Interest Income | 905,699,262,464.00 |
![]() | Johnson & Johnson - Interest Income | 486,508,953,600.00 |
![]() | AbbVie Inc - Interest Income | 399,570,305,024.00 |
![]() | Roche Holding AG - Interest Income | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Interest Income | 280,205,508,085.11 |